Delivery Order SPE2DB24D9131-SPE2DB25FXRS8
- Not listed
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this award. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, was executed without a set-aside designation. The delivery is scheduled for the Park Ridge, IL location, and represents a specific...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.46 to DMS Pharmaceutical Group Inc. for the supply of Stelara 130 mg/26 mL vials. This award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The delivery location is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations as a woman-owned small business pharmaceutical wholesaler. This delivery...
- The Defense Logistics Agency (DLA) awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 22, 2025, for the supply of Stelara 90 mg/ml syringes. The award carries an ultimate completion date of August 12, 2025, and involves no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on July 29, 2025, for the supply of Stelara 90 mg/mL syringes with a ceiling value of $16,249.95. This firm fixed-price delivery order is expected to reach ultimate completion by August 19, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on July 18, 2025, for the supply of Stelara 90 mg/ml syringes. This delivery order was issued without a set-aside designation and is scheduled for completion by August 8, 2025, with performance taking place in Park Ridge, Illinois. The award represents a continuation of DMS...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under the company's larger Indefinite Delivery Contract with DLA, valued at...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of 130 mg/26 ml vials of Stelara, a biologic medication, with a period of performance through September 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRS8Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, IL. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The broader IDC, awarded under the SPE2DB program, establishes DMS Pharmaceutical Group as a key supplier in the federal pharmaceutical supply chain, enabling the agency to procure a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. Stelara is a specialty pharmaceutical product, and this delivery order represents one of numerous pharmaceutical item procurements DMS Pharmaceutical Group fulfills for the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/12/25 |